About
Technology
Issues
FAQ
Title
Abstract
Text
Figure Captions
Table Cells
Section Titles
Keywords
Subjects
Authors
From
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
2011
2010
2009
2008
2007
2006
2005
2004
2003
2002
2001
2000
1995
1990
1985
1980
1975
1970
1960
1950
1940
1930
1920
1910
1900
1850
1800
1700
1600
To
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
2011
2010
2009
2008
2007
2006
2005
2004
2003
2002
2001
2000
1995
1990
1985
1980
1975
1970
1960
1950
1940
1930
1920
1910
1900
1850
1800
1700
1600
All Types
Articles
Communications
Reviews
Discussions
Case Reports
Chapters
Books
News
Editorials
Order By
Order By Year ASC
Order By Year DESC
Order By Citations ASC
Order By Citations DESC
Go
Scientometrics
Impact Factor
Discipline Ranks
H-Index
G-Index
Articles
Citations
Article Citations
Citation Distribution
Search This Journal
Overviews
Top Institutions
Top Schools
Top Authors
Prolific Authors
Top Articles
exaly
›
Journals
›
Journal of Thrombosis and Thrombolysis
›
Top Articles
Journal of Thrombosis and Thrombolysis
Hematology
5.1
(top 2%)
Impact Factor
5.5
(top 2%)
extended IF
70
(top 6%)
H-Index
2.2K
authors
3.4K
papers
41.3K
citations
4.1K
citing journals
24.4K
citing authors
Most Cited Articles of Journal of Thrombosis and Thrombolysis
Title
Year
Citations
The epidemiology of venous thromboembolism
2016
477
COVID-19 update: Covid-19-associated coagulopathy
2020
325
Streptokinase and Heparin versus Heparin Alone in Massive Pulmonary Embolism: A Randomized Controlled Trial
1995
292
Thromboembolism and anticoagulant therapy during the COVID-19 pandemic: interim clinical guidance from the anticoagulation forum
2020
266
The epidemiology of venous thromboembolism in the community: implications for prevention and management
2006
264
Difference of coagulation features between severe pneumonia induced by SARS-CoV2 and non-SARS-CoV2
2021
254
Remodeling the blood coagulation cascade
2003
222
Guidance for the treatment and prevention of obstetric-associated venous thromboembolism
2016
214
Guidance for the practical management of the direct oral anticoagulants (DOACs) in VTE treatment
2016
210
Thrombolytic therapy in pregnancy
2006
196
Incidence and cost burden of post-thrombotic syndrome
2009
190
Pharmacogenetics of warfarin: regulatory, scientific, and clinical issues
2008
186
Value of platelet/lymphocyte ratio as a predictor of all-cause mortality after non-ST-elevation myocardial infarction
2012
185
Drug and dietary interactions of warfarin and novel oral anticoagulants: an update
2011
173
Genotypes of the cytochrome p450 isoform, CYP2C9, and the vitamin K epoxide reductase complex subunit 1 conjointly determine stable warfarin dose: a prospective study
2006
169
Guidance for the treatment of deep vein thrombosis and pulmonary embolism
2016
167
Guidance for the evaluation and treatment of hereditary and acquired thrombophilia
2016
158
Incidence rates, clinical profile, and outcomes of patients with venous thromboembolism. The Worcester VTE study
2009
151
Systematic assessment of venous thromboembolism in COVID-19 patients receiving thromboprophylaxis: incidence and role of D-dimer as predictive factors
2020
142
Guidance for the prevention and treatment of cancer-associated venous thromboembolism
2016
138
Preclinical discovery of apixaban, a direct and orally bioavailable factor Xa inhibitor
2011
133
Evaluation of coagulation function by rotation thromboelastometry in critically ill patients with severe COVID-19 pneumonia
2020
127
Sepsis and disseminated intravascular coagulation
2003
124
COVID-19 and ischemic stroke: a systematic review and meta-summary of the literature
2020
124
Clinical Features of Emergency Department Patients Presenting with Symptoms Suggestive of Acute Cardiac Ischemia: A Multicenter Study
1998
120
0
1
2
next
How are inpact factors calculated?
The impact factor (IF) is calculated by counting citations from peer-reviewed journals only.
extended IF
also counts citations from books and conference papers. However, no patent, abstract, working papers, online documents, etc., are covered.
site/software ©
exaly
; All materials licenced under
CC by-SA
.